Academic
Publications
Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: Complete 2-year follow-up of a two-center registry

Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: Complete 2-year follow-up of a two-cente

Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: Complete 2-year follow-up of a two-center registry   (Citations: 2)
BibTex | RIS | RefWorks Download
Kyung Woo Park, Si-Hyuck Kang, Keun-Ho Park, Dong-Hyun Choi, Hae-Young Lee, Hyun-Jae Kang, Young-Seok Cho, Tae-Jin Yeon, Woo-Young Chung, Bon-Kwon Koo, In-Ho Chae, Dong-Ju Choihttp://academic.research.microsoft.com/io.ashx?type=5&id=30038957&selfId1=0&selfId2=0&maxNumber=12&query=
BackgroundThe feasibility of percutaneous coronary intervention (PCI) using drug-eluting stents and its comparability with bypass surgery in treatment of unprotected left main coronary artery (LMCA) stenosis has been shown previously. We compared the mid-to long-term outcome between sirolimus-(SES) vs. paclitaxel-eluting stents (PES) in an all-comer analysis that included all patients with unprotected LMCA stenosis who underwent PCI with SES or PES.
Journal: International Journal of Cardiology - INT J CARDIOL , vol. 151, no. 1, pp. 89-95, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: